| |
| |
|
| Insider
Information: |
Ashton William |
| Relationship: |
Director |
| City: |
Bethesda |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
80,688 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$54,560 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
80,688 |
|
|
| Total
Value |
$54,560 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 149.6%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sucampo Pharmaceuticals, Inc. |
SCMP |
Director |
2015-03-12 |
0 |
2015-03-11 |
0 |
Premium* |
|
|
SELLAS Life Sciences Group Inc |
SLS |
Director |
2017-10-10 |
38,154 |
2017-01-20 |
0 |
Premium* |
|
|
Societal CDMO, Inc |
SCTL |
Director |
2024-04-08 |
0 |
2018-05-04 |
0 |
Premium* |
|
|
Spectrum Pharmaceuticals Inc |
SPPI |
Director |
2023-07-31 |
0 |
2018-06-18 |
0 |
Premium* |
|
|
Baudax Bio, Inc. |
BXRX |
Director |
2022-06-15 |
42,534 |
2019-12-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
35 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SPPI |
Spectrum Pharmaceuticals ... |
Director |
– • – |
2022-06-21 |
4 |
AS |
$0.79 |
$3,362 |
D/D |
(4,283) |
42,660 |
0 |
% |
|
| SCTL |
Societal CDMO, Inc |
Director |
– • – |
2023-08-28 |
4 |
B |
$0.46 |
$10,111 |
D/D |
22,222 |
263,622 |
2.39 |
% |
|
| SPPI |
Spectrum Pharmaceuticals ... |
Director |
– • – |
2023-07-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(67,660) |
0 |
0 |
- |
|
| SCTL |
Societal CDMO, Inc |
Director |
– • – |
2024-04-08 |
4 |
D |
$1.10 |
$209,002 |
D/D |
(190,002) |
73,620 |
0 |
- |
|
| SCTL |
Societal CDMO, Inc |
Director |
– • – |
2024-04-08 |
4 |
D |
$1.10 |
$80,982 |
D/D |
(73,620) |
0 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
Director |
– • – |
2015-03-11 |
4 |
OE |
$3.56 |
$329,741 |
D/D |
74,004 |
904 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
Director |
– • – |
2015-03-12 |
4 |
OE |
$6.80 |
$432,959 |
D/D |
55,762 |
16,666 |
0 |
- |
|
| SCTL |
Societal CDMO, Inc |
Director |
– • – |
2018-05-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,274 |
19,457 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
Director |
– • – |
2015-03-11 |
4 |
S |
$17.32 |
$1,281,749 |
D/D |
(74,004) |
0 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
Director |
– • – |
2015-03-12 |
4 |
S |
$17.55 |
$978,623 |
D/D |
(55,762) |
0 |
0 |
- |
|
35 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
